RE: Oxford Nanopore prices IPO to give valuation of up to $4.77 billion23 Sep 2021 09:21
Yep. "LONDON (Reuters) - The initial public offering for Oxford Nanopore, a provider of rapid COVID-19 tests to Britain's national health services, will have an indicative price of 375 to 450 pence per share, a bookrunner said on Thursday.
The offer will total 523 million pounds ($713.16 million) to 547 million pounds, giving the life sciences company an implied market capitalisation of 3 billion to 3.5 billion pounds , the bookrunner said."